tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

CAPR Stock Latest News

Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Press ReleasesCapricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
25d ago
CAPR
CAPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsCAPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
27d ago
CAPR
Capricor Therapeutics announces publication on StealthX Platform
The FlyCapricor Therapeutics announces publication on StealthX Platform
1M ago
CAPR
Capricor Therapeutics Presents at 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Press ReleasesCapricor Therapeutics Presents at 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
2M ago
CAPR
Capricor Therapeutics presents results from HOPE-2 OLE study of CAP-1002
The FlyCapricor Therapeutics presents results from HOPE-2 OLE study of CAP-1002
2M ago
CAPR
Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Press ReleasesCapricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
3M ago
CAPR
Capricor Therapeutics to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on March 15
Press ReleasesCapricor Therapeutics to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on March 15
3M ago
CAPR
Capricor Therapeutics Receives Clinical Research Forum’s 2023 Top Ten Clinical Research Achievement Award
Press ReleasesCapricor Therapeutics Receives Clinical Research Forum’s 2023 Top Ten Clinical Research Achievement Award
3M ago
CAPR
Capricor Therapeutics and Nippon Shinyaku Enter Partnership for Exclusive Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in Japan
Press ReleasesCapricor Therapeutics and Nippon Shinyaku Enter Partnership for Exclusive Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in Japan
4M ago
CAPR
Capricor, Nippon Shinyaku enter commercialization, distribution partnership
The FlyCapricor, Nippon Shinyaku enter commercialization, distribution partnership
4M ago
CAPR
Capricor Therapeutics Announces Positive 18-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy Patients
Press ReleasesCapricor Therapeutics Announces Positive 18-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy Patients
4M ago
CAPR
Capricor announces 18-month results from ongoing HOPE-2 OLE study of CAP-1002
The FlyCapricor announces 18-month results from ongoing HOPE-2 OLE study of CAP-1002
4M ago
CAPR
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Provide Recent Updates on CAP-1002 Program
Press ReleasesCapricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Provide Recent Updates on CAP-1002 Program
5M ago
CAPR
Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform
Press ReleasesCapricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform
5M ago
CAPR
Capricor Therapeutics announces publication engineered exosome platform
The FlyCapricor Therapeutics announces publication engineered exosome platform
5M ago
CAPR
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15
Stock Analysis & Ideas2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15
6M ago
VOR
CAPR
Capricor Therapeutics reports Q3 EPS (26c), consensus (29c)
The FlyCapricor Therapeutics reports Q3 EPS (26c), consensus (29c)
7M ago
CAPR
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesCapricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7M ago
CAPR
Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10
Press ReleasesCapricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10
7M ago
CAPR
Capricor Therapeutics to Present One-Year Results from HOPE-2 Open Label Extension Study at World Muscle Society 2022
Press ReleasesCapricor Therapeutics to Present One-Year Results from HOPE-2 Open Label Extension Study at World Muscle Society 2022
8M ago
CAPR
Capricor Therapeutics to Present at Upcoming Investor Conferences
Press ReleasesCapricor Therapeutics to Present at Upcoming Investor Conferences
9M ago
CAPR
Capricor Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy
Press ReleasesCapricor Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy
11M ago
CAPR